The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens

Table 1

Demographic and clinical data for the BC patients and the control.

Patients
Total number ()	91
Male/female	74/17
Age (years) (mean ± SD)	68 ± 9.5
Smokers number	64 (75.3%)
Clinical grading
Ta	43 (45.3%)
T1	31 (34.1%)
T2	10 (11%)
TIS	7 (7.7%)
Clinical staging
G1	40 (47.6%)
G2	41 (48.8%)
G3	3 (3.6%)
Controls total number ()	25
Male/female	18/7
Age (years) (mean ± SD)	65 ± 6.9
Smokers number	19 (76%)